164 related articles for article (PubMed ID: 1317164)
21. Melittin stimulates liver glycogenolysis and the release of prostaglandin D2 and thromboxane B2.
García-Sáinz JA; Hernández-Sotomayor SM; Macías-Silva M
Biochem J; 1990 Jul; 269(1):273-5. PubMed ID: 2375756
[TBL] [Abstract][Full Text] [Related]
22. Effect of nonsteroidal anti-inflammatory drugs on glycogenolysis in isolated hepatocytes.
Brass EP; Garrity MJ
Br J Pharmacol; 1985 Oct; 86(2):491-6. PubMed ID: 3863682
[TBL] [Abstract][Full Text] [Related]
23. Further evidence for role of leukotrienes as mediators of decidualization in the rat.
Tawfik OW; Dey SK
Prostaglandins; 1988 Mar; 35(3):379-86. PubMed ID: 2836890
[TBL] [Abstract][Full Text] [Related]
24. Possible involvement of cyclooxygenase products in the actions of platelet-activating factor and of lipoxygenase products in the vascular effects of epinephrine in perfused rat liver.
Mendlovic F; Corvera S; García-Sáinz JA
Biochem Biophys Res Commun; 1984 Sep; 123(2):507-14. PubMed ID: 6435614
[TBL] [Abstract][Full Text] [Related]
25. Glycogenolytic and haemodynamic responses to heat-aggregated immunoglobulin G and prostaglandin E2 in the perfused rat liver.
Buxton DB; Fisher RA; Briseno DL; Hanahan DJ; Olson MS
Biochem J; 1987 Apr; 243(2):493-8. PubMed ID: 2820382
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of [Asu1 . 7]-eel calcitonin on glucagon-induced glycogenolysis in perfused rat liver.
Mine T; Kimura S; Ogata E
Horm Metab Res; 1983 Mar; 15(3):139-43. PubMed ID: 6303930
[TBL] [Abstract][Full Text] [Related]
27. Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.
Kroegel C; Matthys H
Immunology; 1993 Feb; 78(2):279-85. PubMed ID: 8473016
[TBL] [Abstract][Full Text] [Related]
28. Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis.
Czop JK; Austen KF
Proc Natl Acad Sci U S A; 1985 May; 82(9):2751-5. PubMed ID: 2986134
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine.
Buxton DB; Shukla SD; Hanahan DJ; Olson MS
J Biol Chem; 1984 Feb; 259(3):1468-71. PubMed ID: 6693418
[TBL] [Abstract][Full Text] [Related]
30. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production.
Shibata Y; Metzger WJ; Myrvik QN
J Immunol; 1997 Sep; 159(5):2462-7. PubMed ID: 9278339
[TBL] [Abstract][Full Text] [Related]
31. Modulation of basal hepatic glycogenolysis by nitric oxide.
Borgs M; Bollen M; Keppens S; Yap SH; Stalmans W; Vanstapel F
Hepatology; 1996 Jun; 23(6):1564-71. PubMed ID: 8675178
[TBL] [Abstract][Full Text] [Related]
32. Eicosanoid-mediated increase in glucose and lactate output as well as decrease and redistribution of flow by complement-activated rat serum in perfused rat liver.
Muschol W; Püschel GP; Hülsmann M; Jungermann K
Eur J Biochem; 1991 Mar; 196(2):525-30. PubMed ID: 2007411
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibition of eicosanoids and platelet-activating factor signaling impairs zymosan-induced release of IL-23 by dendritic cells.
Rodríguez M; Márquez S; Montero O; Alonso S; Frade JG; Crespo MS; Fernández N
Biochem Pharmacol; 2016 Feb; 102():78-96. PubMed ID: 26673542
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D1 macrophages.
Schaloske RH; Provins JW; Kessen UA; Dennis EA
Biochim Biophys Acta; 2005 Feb; 1687(1-3):64-75. PubMed ID: 15708354
[TBL] [Abstract][Full Text] [Related]
35. Evidence that Ca2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-alpha-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathway.
Altin JG; Dieter P; Bygrave FL
Biochem J; 1987 Jul; 245(1):145-50. PubMed ID: 3117040
[TBL] [Abstract][Full Text] [Related]
36. Platelet-activating factor-mediated synthesis of prostaglandins in rat Kupffer cells.
Gandhi CR; DeBuysere MS; Olson MS
Biochim Biophys Acta; 1992 Jul; 1136(1):68-74. PubMed ID: 1322709
[TBL] [Abstract][Full Text] [Related]
37. Specific antagonists of platelet activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver.
Buxton DB; Hanahan DJ; Olson MS
Biochem Pharmacol; 1986 Mar; 35(6):893-7. PubMed ID: 3754140
[TBL] [Abstract][Full Text] [Related]
38. CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes.
Elstad MR; Parker CJ; Cowley FS; Wilcox LA; McIntyre TM; Prescott SM; Zimmerman GA
J Immunol; 1994 Jan; 152(1):220-30. PubMed ID: 7902855
[TBL] [Abstract][Full Text] [Related]
39. Acrylyl-PAF, a synthetic platelet-activating factor analogue.
Duffy-Krywicki RH; Steinhelper ME; Olson MS
J Lipid Mediat; 1991; 3(3):345-59. PubMed ID: 1773032
[TBL] [Abstract][Full Text] [Related]
40. Differences in the involvement of prostanoids from Kupffer cells in the mediation of anaphylatoxin C5a-, zymosan-, and lipopolysaccharide-dependent hepatic glucose output and flow reduction.
Pestel S; Schlaf G; Götze O; Jungermann K; Schieferdecker HL
Lab Invest; 2003 Dec; 83(12):1733-41. PubMed ID: 14691291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
